Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mapping Cancer's next move: study tracks where prostate cancer returns after aggressive radiotherapy

NCT ID NCT07686016

Recruiting now Knowledge-focused Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study follows 700 men with prostate cancer that has spread to up to 10 spots in the body (oligometastatic). All receive radiotherapy to the prostate and to each visible metastasis, along with standard systemic therapy. Researchers collect real-world data from medical records to see where and when the cancer progresses after this comprehensive treatment. The goal is to understand patterns of failure and identify factors linked to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiotherapy
What this could lead to
If successful, this could help doctors better predict and manage prostate cancer that has spread to a few spots, potentially improving treatment plans.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove what treatment works best. Results may vary based on routine care differences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC PROSTATE CANCER OLIGOMETASTATIC PROSTATE CANCER PROSTATE CANCER SYNCHRONOUS OLIGOMETASTATIC PROSTATE CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affidea Nu-med Center of Oncological Diagnostics and Therapy

    RECRUITING

    Zamość, Lublin Voivodeship, 22-400, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.